Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Clinical trial NCT01028859 · COMPLETED

Trial details

NCT number: NCT01028859
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2009-12-01
Primary completion: 2011-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.